ABSTRACT
Objectives To assess the responsiveness of the National Health Insurance Fund (NHIF) Supa Cover benefit package to the needs of individuals with diabetes and hypertension in Kenya.
Design, setting and participants We carried out a qualitative study and collected data using key informant interviews (n = 39) and focus group discussions (n = 4) in two purposively selected counties in Western Kenya. Study participants were drawn from NHIF officials, county government officials, health facility managers, healthcare workers and individuals with NCDs who were enrolled in NHIF. We analysed data using thematic analysis.
Results Study participants reported that the NHIF Supa Cover benefit package expanded access to services for people living with NCDs. However, the NHIF members and healthcare workers had inadequate awareness of the NHIF service entitlements. The NHIF benefit package inadequately covered the range of services needed by people living with NCDs and the benefits package did not prioritise preventive and promotive services. Sometimes NCD patients were discriminated against by healthcare providers who preferred cash-paying patients, and some NHIF-empanelled health facilities had inadequate structural inputs essential for quality of care. Study participants felt that the NHIF premium for the general scheme was unaffordable, and NHIF members faced additional out-of-pocket costs because of additional payments for services not available or covered.
Conclusion Whereas NHIF has reduced financial barriers for NCD patients, to enhance its responsiveness to patient needs, NHIF should implement mechanisms to increase benefit package awareness among members and providers. In addition, preventive and promotive services should be included in NHIF’s benefits package and mechanisms to monitor and hold contracted providers accountable should be strengthened.
Strengths and limitations of this study
Strengths and limitations of this study
This study used in-depth interviews and focus group discussions to comprehensively examine how responsive the national health insurance fund is to the healthcare needs of patients with chronic conditions.
The study recruited participants from both urban and rural sites and health staff from a range of cadres and thus provides evidence from a wide range of respondents with varied experiences.
Including chronic disease patients who had discontinued membership from the national health insurance scheme could have yielded richer findings on the scheme’s responsiveness.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the UK Medical Research Council grant number MR/T023538/1. RO is funded by a Wellcome Trust International Masters award (#214622), and additional funds from a Wellcome Trust core grant awarded to the KEMRI-Wellcome Trust Research Program (#092654) supported this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed and approved by the Institutional Ethics and Research Committee of Moi University (IREC 0003586) and the London School of Hygiene and Tropical Medicine (17940).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
